Search results for

Rep. Norma Torres, D-Calif., gave an impassioned account of the events that took place on Jan. 6, when a mob of pro-Trump extremists breached the Capitol and forced lawmakers into hiding.

President Biden's approval rating slid to just 43%, according to a new NPR/PBS NewsHour/Marist poll. The decline is principally due to independents, a key swing group.

In his closing remarks, Michael van der Veen said Trump's words on the day of the Capitol insurrection were taken out of context and that any comments he did make are protected speech.

"Throughline" has so far been a hit as a history podcast. And now, it's debuted on public radio stations across the country.It's not the kind of show…

Johnson, a big Trump supporter, is facing scrutiny for comments including whether the Capitol insurrection was "armed." Some worry he might renege on a pledge not to run for a 3rd term.

After a tough financial year for the beauty industry, salons are seeing a much welcome boost in bookings now that more adults in the U.S. are vaccinated.

NPR member stations share a mix of popular songs playing on their airwaves in October, including music from alt-J, Anderson .Paak, The Killers and more.

It's been two years since the heads of most leading economies met in person. "We can finally look at the future with great — or with some — optimism," said Italy's Mario Draghi, the summit host.

The Champlain Towers South condo association will now be overseen by a receiver who will handle all of the association's financial matters. It comes as questions swirl about the condo's collapse.

In India, Hindu nationalists have passed laws making it harder for interfaith couples to marry. The laws have increased a stigma and emboldened extremists to interrupt weddings.

After two recent attacks on the U.S. Capitol — Jan. 6 and the breach last week when a man rammed a barrier, killing an officer — a debate over fencing and stepped up security is front and center.

People who were addicted to OxyContin or lost loved ones who were addicted to the drug expect very little in compensation from the multibillion-dollar Purdue Pharma bankruptcy settlement.